Advertisement

Relation of Cardiac Complications in the Early Phase of Community-Acquired Pneumonia to Long-Term Mortality and Cardiovascular Events

      Community-acquired pneumonia (CAP) is complicated by cardiac events in the early phase of the disease. Aim of this study was to assess if these intrahospital cardiac complications may account for overall mortality and cardiovascular events occurring during a long-term follow-up. Three hundred one consecutive patients admitted to the University-Hospital, Policlinico Umberto I, with community-acquired pneumonia were prospectively recruited and followed up for a median of 17.4 months. Primary end point was the occurrence of death for any cause, and secondary end point was the occurrence of cardiovascular events (cardiovascular death, nonfatal myocardial infarction [MI], and stroke). During the intrahospital stay, 55 patients (18%) experienced a cardiac complication. Of these, 32 had an MI (29 non–ST-elevation MI and 3 ST-elevation MI) and 30 had a new episode of atrial fibrillation (7 nonmutually exclusive events). During the follow-up, 89 patients died (51% of patients with an intrahospital cardiac complication and 26% of patients without, p <0.001) and 73 experienced a cardiovascular event (47% of patients with and 19% of patients without an intrahospital cardiac complication, p <0.001). A Cox regression analysis showed that intrahospital cardiac complications, age, and Pneumonia Severity Index were significantly associated with overall mortality, whereas intrahospital cardiac complications, age, hypertension, and diabetes were significantly associated with cardiovascular events during the follow-up. In conclusion, this prospective study shows that intrahospital cardiac complications in the early phase of pneumonia are associated with an enhanced risk of death and cardiovascular events during long-term follow-up.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • McCabe C.
        • Kirchner C.
        • Zhang H.
        • Daley J.
        • Fisman D.N.
        Guideline-concordant therapy and reduced mortality and length of stay in adults with community-acquired pneumonia: playing by the rules.
        Arch Intern Med. 2009; 169: 1525-1531
        • Violi F.
        • Cangemi R.
        • Calvieri C.
        Pneumonia, thrombosis and vascular disease.
        J Thromb Haemost. 2014; 12: 1391-1400
        • Corrales-Medina V.F.
        • Musher D.M.
        • Shachkina S.
        • Chirinos J.A.
        Acute pneumonia and the cardiovascular system.
        Lancet. 2013; 381: 496-505
        • Corrales-Medina V.F.
        • Musher D.M.
        • Wells G.A.
        • Chirinos J.A.
        • Chen L.
        • Fine M.J.
        Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality.
        Circulation. 2012; 125: 773-781
        • Venditti M.
        • Falcone M.
        • Corrao S.
        • Licata G.
        • Serra P.
        • Study Group of the Italian Society of Internal Medicine
        Outcomes of patients hospitalized with community-acquired, health care-associated, and hospital-acquired pneumonia.
        Ann Intern Med. 2009; 150: 19-26
        • Aujesky D.
        • Fine M.J.
        The Pneumonia Severity Index: a decade after the initial derivation and validation.
        Clin Infect Dis. 2008; 47: S133-S139
        • Perk J.
        • De Backer G.
        • Gohlke H.
        • Graham I.
        • Reiner Z.
        • Verschuren M.
        • Albus C.
        • Benlian P.
        • Boysen G.
        • Cifkova R.
        • Deaton C.
        • Ebrahim S.
        • Fisher M.
        • Germano G.
        • Hobbs R.
        • Hoes A.
        • Karadeniz S.
        • Mezzani A.
        • Prescott E.
        • Ryden L.
        • Scherer M.
        • Syvanne M.
        • Scholte op Reimer W.J.
        • Vrints C.
        • Wood D.
        • Zamorano J.L.
        • Zannad F.
        • European Association for Cardiovascular Prevention & Rehabilitation (EACPR); ESC Committee for Practice Guidelines (CPG)
        European guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts).
        Eur Heart J. 2012; 33: 1635-1701
        • Rabe K.F.
        • Hurd S.
        • Anzueto A.
        • Barnes P.J.
        • Buist S.A.
        • Calverley P.
        • Fukuchi Y.
        • Jenkins C.
        • Rodriguez-Roisin R.
        • van Weel C.
        • Zielinski J.
        • Global Initiative for Chronic Obstructive Lung Disease
        Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.
        Am J Respir Crit Care Med. 2007; 176: 532-555
        • Camm A.J.
        • Kirchhof P.
        • Lip G.Y.
        • Schotten U.
        • Savelieva I.
        • Ernst S.
        • Van Gelder I.C.
        • Al-Attar N.
        • Hindricks G.
        • Prendergast B.
        • Heidbuchel H.
        • Alfieri O.
        • Angelini A.
        • Atar D.
        • Colonna P.
        • De Caterina R.
        • De Sutter J.
        • Goette A.
        • Gorenek B.
        • Heldal M.
        • Hohloser S.H.
        • Kolh P.
        • Le Heuzey J.Y.
        • Ponikowski P.
        • Rutten F.H.
        • European Heart Rhythm Association
        • European Association for Cardio-Thoracic Surgery
        Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).
        Eur Heart J. 2010; 31: 2369-2429
        • Thygesen K.
        • Alpert J.S.
        • Jaffe A.S.
        • Simoons M.L.
        • Chaitman B.R.
        • White H.D.
        • Writing Group on the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction
        • ESC Committee for Practice Guidelines (CPG)
        Third universal definition of myocardial infarction.
        Eur Heart J. 2012; 33: 2551-2567
        • Kernan W.N.
        • Ovbiagele B.
        • Black H.R.
        • Bravata D.M.
        • Chimowitz M.I.
        • Ezekowitz M.D.
        • Fang M.C.
        • Fisher M.
        • Furie K.L.
        • Heck D.V.
        • Johnston S.C.
        • Kasner S.E.
        • Kittner S.J.
        • Mitchell P.H.
        • Rich M.W.
        • Richardson D.
        • Schwamm L.H.
        • Wilson J.A.
        • American Heart Association Stroke Council CoC
        • Stroke Nursing CoCC
        • Council on Peripheral Vascular Disease
        Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.
        Stroke. 2014; 45: 2160-2236
        • Cangemi R.
        • Casciaro M.
        • Rossi E.
        • Calvieri C.
        • Bucci T.
        • Calabrese C.M.
        • Taliani G.
        • Falcone M.
        • Palange P.
        • Bertazzoni G.
        • Farcomeni A.
        • Grieco S.
        • Pignatelli P.
        • Violi F.
        • Group SS
        • Group SS
        Platelet activation is associated with myocardial infarction in patients with pneumonia.
        J Am Coll Cardiol. 2014; 64: 1917-1925
        • Mandal P.
        • Chalmers J.D.
        • Choudhury G.
        • Akram A.R.
        • Hill A.T.
        Vascular complications are associated with poor outcome in community-acquired pneumonia.
        QJM. 2011; 104: 489-495
        • Corrales-Medina V.F.
        • Alvarez K.N.
        • Weissfeld L.A.
        • Angus D.C.
        • Chirinos J.A.
        • Chang C.C.
        • Newman A.
        • Loehr L.
        • Folsom A.R.
        • Elkind M.S.
        • Lyles M.F.
        • Kronmal R.A.
        • Yende S.
        Association between hospitalization for pneumonia and subsequent risk of cardiovascular disease.
        JAMA. 2015; 313: 264-274
        • Dharmarajan K.
        • Hsieh A.F.
        • Kulkarni V.T.
        • Lin Z.
        • Ross J.S.
        • Horwitz L.I.
        • Kim N.
        • Suter L.G.
        • Lin H.
        • Normand S.L.
        • Krumholz H.M.
        Trajectories of risk after hospitalization for heart failure, acute myocardial infarction, or pneumonia: retrospective cohort study.
        BMJ. 2015; 350: h411
        • Zethelius B.
        • Johnston N.
        • Venge P.
        Troponin I as a predictor of coronary heart disease and mortality in 70-year-old men: a community-based cohort study.
        Circulation. 2006; 113: 1071-1078
        • Falcone M.
        • Russo A.
        • Cangemi R.
        • Farcomeni A.
        • Calvieri C.
        • Barilla F.
        • Scarpellini M.G.
        • Bertazzoni G.
        • Palange P.
        • Taliani G.
        • Venditti M.
        • Violi F.
        Lower mortality rate in elderly patients with community-onset pneumonia on treatment with aspirin.
        J Am Heart Assoc. 2015; 4: e001595
        • Santos-Gallego C.G.
        • Badimon J.J.
        The sum of two evils: pneumonia and myocardial infarction: is platelet activation the missing link?.
        J Am Coll Cardiol. 2014; 64: 1926-1928
        • Corrales-Medina V.F.
        • Madjid M.
        • Musher D.M.
        Role of acute infection in triggering acute coronary syndromes.
        Lancet Infect Dis. 2010; 10: 83-92

      Linked Article

      • Cardiac Complications After Community-Acquired Pneumonia
        American Journal of CardiologyVol. 117Issue 2
        • Preview
          We read with interest the report by Cangemi et al1 “Relation of cardiac complications in the early phase of community-acquired pneumonia (CAP) to long-term mortality and cardiovascular events” published in the August 5th issue of the American Journal of Cardiology. The investigators show that 18% of patients with CAP study develop intrahospital cardiac complications, defined as myocardial infarction (MI) and atrial fibrillation. Furthermore, the investigators prospectively show that these cardiac complications in the early phase of CAP are associated with adverse long-term cardiovascular prognosis (with the end point being cardiovascular death, nonfatal MI, and stroke).
        • Full-Text
        • PDF